aminoacylase 3 inhibitors (University of California Los Angeles)

N/A

Report date: 2025/03/14 16:40:29
NME

Base Information

Drug Nameaminoacylase 3 inhibitors (University of California Los Angeles)
Drug Alias NameAa3 inhibitors (University of California Los Angeles)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHydrolases inhibitors
TargetsHydrolases
Therapy Area/IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of California, Los Angeles
China Registration ClassN/A

Develop Information

Active CompaniesUniversity Of CaliforniaUniversity Of California, Los Angeles
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsNerve DegenerationAlzheimer DiseaseParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A